REGULATED INFORMATION Nyxoah Issues First Half 2021 Financial Results Mont-Saint-Guibert, Belgium – August 31, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of
PICKERING, Ontario, Aug. 31, 2021 (GLOBE NEWSWIRE) — TJP Labs Inc. (“TJP Labs”), one of North America’s leading full-service contract manufacturers of next-generation nicotine products, announced its launch of Canada’s first modern oral nicotine contract manufacturing facility for buccal nicotine
EDMONTON, Alberta, Aug. 31, 2021 (GLOBE NEWSWIRE) — Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment of first patient in the LidERA Breast Cancer (TRIO045) trial, a Phase 3 randomized, multi-center, open-label global clinical
VILNIUS, Lithuania, Aug. 31, 2021 (GLOBE NEWSWIRE) — Peplink is partnering with Ericsson to deliver SpeedFusion technology to Industry 4.0 networks – allowing for greater scalability and seamless switching between different edge technologies so industrial networks can grow and remain
Hein Schumacher ROSEMONT, Ill., Aug. 31, 2021 (GLOBE NEWSWIRE) — Global Dairy Platform (GDP), a not-for-profit industry association representing the international dairy sector, today announced the appointment of Hein Schumacher, Chief Executive Officer of Royal FrieslandCampina, as Chair of GDP’s
WILMINGTON, N.C. and DUBAI, United Arab Emirates, Aug. 31, 2021 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced its participation in the Middle East
Second quarter total revenue of $1,021.5 million, up 54% year over year Number of customers contributing more than $100,000 in TTM revenue up 131% year over year Second quarter GAAP operating margin of 28.8% and non-GAAP operating margin of 41.6%
SHANGHAI, China, Aug. 31, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the six months ended June 30,
REGULATED INFORMATION Nyxoah Issues First Half 2021 Financial Results Mont-Saint-Guibert, Belgium – August 31, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of
PICKERING, Ontario, Aug. 31, 2021 (GLOBE NEWSWIRE) — TJP Labs Inc. (“TJP Labs”), one of North America’s leading full-service contract manufacturers of next-generation nicotine products, announced its launch of Canada’s first modern oral nicotine contract manufacturing facility for buccal nicotine
EDMONTON, Alberta, Aug. 31, 2021 (GLOBE NEWSWIRE) — Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment of first patient in the LidERA Breast Cancer (TRIO045) trial, a Phase 3 randomized, multi-center, open-label global clinical
VILNIUS, Lithuania, Aug. 31, 2021 (GLOBE NEWSWIRE) — Peplink is partnering with Ericsson to deliver SpeedFusion technology to Industry 4.0 networks – allowing for greater scalability and seamless switching between different edge technologies so industrial networks can grow and remain
Hein Schumacher ROSEMONT, Ill., Aug. 31, 2021 (GLOBE NEWSWIRE) — Global Dairy Platform (GDP), a not-for-profit industry association representing the international dairy sector, today announced the appointment of Hein Schumacher, Chief Executive Officer of Royal FrieslandCampina, as Chair of GDP’s
WILMINGTON, N.C. and DUBAI, United Arab Emirates, Aug. 31, 2021 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced its participation in the Middle East
Second quarter total revenue of $1,021.5 million, up 54% year over year Number of customers contributing more than $100,000 in TTM revenue up 131% year over year Second quarter GAAP operating margin of 28.8% and non-GAAP operating margin of 41.6%
SHANGHAI, China, Aug. 31, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the six months ended June 30,
